With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Improving CAR T-Cell Therapy for Pediatric Osteosarcoma by Manipulating Arginine Metabolism||St. Jude Children's Research Hospital / Shannon Lange, PhD||Young Investigator Grants||2019||Tennessee|
|Identification of Synthetically Immunogenic Compounds to Synergize with Immunotherapy in Neuroblastoma||Children's Hospital of Philadelphia / Adam Wolpaw, MD/PhD||Young Investigator Grants||2019||Pennsylvania|
|The Impact Of CD56neg NK Cells in the Pathogenesis of Endemic Burkitt Lymphoma||University of Massachusetts Medical School / Catherine Forconi, PhD||Young Investigator Grants||2019||Massachusetts|
|Targeting Valine-Specific Amino Acid Dependency -in T-Cell Acute Lymphoblastic Leukemia||New York University School of Medicine / Palaniraja Thandapani, PhD||Young Investigator Grants||2019||New York|
|Enhancing the therapeutic efficacy of chimeric antigen receptor T cells for acute myeloid leukemia||Washington University / Miriam Kim, MD||Young Investigator Grants||2019||Missouri|
|Characterization of Chromatin Landscapes to Identify Therapeutic Vulnerabilities in Diffuse Midline Gliomas.||Fred Hutchinson Cancer Research Center / Jay Sarthy, MD/PhD||Young Investigator Grants||2019||Washington|
|Modeling H3 G34R and BCOR-Altered Glioma Pathogenesis Using Neural Stem Cells||The Johns Hopkins University School of Medicine / Satoshi Nakata, MD/PhD||Young Investigator Grants||2019||Maryland|
|Kidney Disease after CD19-Targeted Chimeric Antigen Receptor T Cell Therapy for Pediatric Acute Lymphoblastic Leukemia||Children's Hospital of Philadelphia / Regina Myers, MD||Young Investigator Grants||2019||Pennsylvania|
|MLL Oncogene-Dependent Enhancer Reprogramming Promotes Leukemogenesis||Stanford University / Feng Pan, PhD||Young Investigator Grants||2019||California|
|The Role of Tumor Heterogeneity in Relapse of Pediatric Acute Myeloid Leukemia||Children's Hospital & Research Center at Oakland / Cheryl Peretz, MD||Young Investigator Grants||2019||California|